Brought to you by 
Takeda options programs discovered through Schrodinger alliance
18 Jun 2020
Executive Summary
Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.
Deal Industry
- Digital Health
- Pharmaceuticals
- Services
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Takeda options programs discovered through Schrodinger alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice